| Systematic (IUPAC) name | |
|---|---|
| N-[1-(2-hydroxy-2-phenylethyl)piperidin-4-yl]-N-phenylpropanamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Schedule I (CA) ? (UK) Schedule I (US) |
| Identifiers | |
| CAS number | 78995-10-5 |
| ATC code | None |
| PubChem | CID 62278 |
| DrugBank | DB01453 |
| ChemSpider | 56079 |
| Synonyms | β-hydroxyfentanyl |
| Chemical data | |
| Formula | C22H28N2O2 |
| Mol. mass | 352.47 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| (what is this?) (verify) |
|
β-hydroxyfentanyl is an opioid analgesic that is an analogue of fentanyl.
β-hydroxyfentanyl was sold briefly on the black market in the early 1980s, before the introduction of the Federal Analog Act which for the first time attempted to control entire families of drugs based on their structural similarity rather than scheduling each drug individually as they appeared. [1]
β-hydroxyfentanyl has similar effects to fentanyl. Side effects of fentanyl analogues are similar to those of fentanyl itself, which include itching, nausea, and respiratory depression, which can be serious and even life-threatening.